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Background: Even with large-scale up routine immunization
programs, measles remains a public health problem, with out-
breaks reported in association with insufﬁcient vaccine coverage
especially in countries recovering fromanatural disasteror conﬂict.
This study aimed at characterizing Rwandan measles genotypes
and compares its seroprevalence to the one from a high income
country, Sweden.
Methods & Materials: Performed in two phases; ﬁrst, a cross-
sectional study, on plasma randomly selected from 118 Rwandan
patients, 120 Swedish patients and 119 young university Swedish
students at Gothenburg University, was carried out to determine
measles seroprevalence. The serological assays measured the Opti-
cal Density (OD) of IgG-antibodies in a high sensitive ELISA using
the morbillivirus in-house antigens from the diagnostic laboratory
of the University of Gothenburg. Positive results were deﬁned as
OD≥0.5.
Second, 544 plasma and 31 nasopharyngeal specimens of sus-
pected measles cases were collected in all provinces of Rwanda
from June 2010 to June 2011. Plasma were analysed for measles-
speciﬁc IgM antibodies titers at the National Reference Laboratory
in Kigali using an ELISA (Enzygnost, Siemens, Marburg, Germany)
according to the instructions provided by the manufacturer. PCR
tests were done at the Uganda Virus Research Institute where
viruses were isolated from nasopharyngial samples using vero-
SLAM cells, and then the Qiagen OneStep RT-PCR kit was used to
perform PCR on the positive isolates.
Results: The seroprevalence rates of measles-speciﬁc IgG anti-
bodies were 94.1%, 94.2% and 96.6% in Rwandan, Swedish patients
and Swedish students respectively.
From phase 2, out of 544 plasma samples collected, 76 were
IgM positive for measles and most outbreak cases located in
regions near the border with the Democratic Republic of Congo
and Burundi.
For the measles suspected cases, 31 nasopharyngeal samples
were collected and 21 were positive on PCR with the predominant
genotype being B3.
Conclusion: Measles immunization coverage and seropreva-
lence was found to be comparable between both the Rwandan
and Swedish study populations.The isolatedmeasles strainwas B3,
which is identical to that found in the most African countries and
in particular those surrounding Rwanda suggesting a possibility
cross border transfer that may have accounted for the in-country
outbreak reported from Rusizi district.
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Background: Several viral pathogens are detected in patients
with acute respiratory infections raising the question of their dis-
ease association especially in the presence of HIV. We investigated
theprevalenceof respiratoryviruses for severeacute respiratory ill-
ness (SARI) to identify viruses in fatal disease compared to patients
with inﬂuenza like illness (ILI) and healthy controls in South Africa.
Methods & Materials: Upper respiratory tract specimens from
fatal cases were collected through a SARI surveillance programme
in South Africa and compared to patients with SARI, ILI or healthy
controls. Specimenswere testedbymultiplex real-timepolymerase
chain reaction (PCR) for 17 respiratory viruses.Multinomial logistic
regression analysis was used to compare SARI and ILI patients to
controls.
Results: Of 3907 patients enrolled from 2012-2013, 2125
(54.39%) had SARI, 1325 (22.91%) ILI and457 (11.70%) were con-
trols of which 36% were < 5 years old. A total of 261 fatal cases
were screened for 2012. The most common virus identiﬁed in
all age groups was rhinovirus followed by adenovirus, KI poly-
omavirus, inﬂuenza A and B and Respiratory Syncytial Virus (RSV).
Inﬂuenza, RSV, hMPV, and rhinovirus were associatedwith both ILI
and SARI relative to controls. The most frequently detected viruses
in the fatal cases were Rhinovirus (17%), Adenovirus (13%), KI Poly-
omavirus (9%), and RSV (5%). In children <1 that died with single
infections, Rhinovirus (16%) and Adenovirus (33%) was detected
most while RSV, PIV3, Enterovirus, Bocavirus and polyomavirus
WU was each detected in 5% of cases. Rhinovirus, Adenovirus, RSV
